IGF-1R is involved in the AKT and ERK signaling pathways (10), suggesting that miR-381 suppresses tumor growth in endometrial carcinoma by directly targeting IGF-1R to modulate the AKT and ERK pathways (11). This evidence concerns the gene AKT1 and endometrial carcinoma.